The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Cardiac output measured by electrical velocimetry in the CT suite correlates with coronary artery enhancement: A feasibility study

På svenska

Author

Summary, in English

Background: Cardiac output (CO) is inversely related to vascular contrast medium (CM) enhancement during computed tomography (CT). Impedance cardiography with a new technique, electrical velocimetry (EV), may create opportunities to measure CO pre-examination for adaptation of CM injection parameters. Purpose: To relate CO EV measured by radiology staff to aortic attenuation as a measure of coronary artery attenuation during CT coronary angiography (CTCA), and to formulate a tentative statistical model to adapt CM injection parameters to CO. Material and Methods: CO EV was measured immediately before 100 kVp CTCA (64-multirow detector) in 27 patients with presumed coronary artery disease. For CTCA, 260 mg I/kg (maximum dosage weight: 8090 kg for womenmen) was injected intravenously during 12 s. Simple linear regression analysis was performed to explore the correlation between aortic attenuation (Hounsfield units, HU) and body weight, the influence of CO EV on aortic attenuation adjusted to injected CM dose rate (HU per mg Ikgs), and to establish a tentative formula on how to adapt CM injection parameters to CO EV and desired aortic attenuation. Results: The correlation between aortic attenuation and body weight was weak and non-significant (r --0.14 after outlier exclusion). A significant negative correlation (r --0.63) was found between aortic attenuation adjusted to injected CM dose rate (HU per mg Ikgs) and CO EV. The resulting formula, CM dose rate = CO EV x (aortic attenuation -240)55, made it possible to calculate CM volumes and injection rates at various COs and, for example, the present mean aortic attenuation (438 HU), injection time (12 s), CM concentration (320 mg Iml), and a certain body weight. Conclusion: EV makes it possible to measure CO in the CT suite before vascular examinations. Hence, CM doses may be decreased in low CO states to reduce the risk of CM-induced nephropathy without jeopardizing diagnostic quality and may be increased in high CO states to avoid poor enhancement.

Publishing year

2010

Language

English

Pages

895-902

Publication/Series

Acta Radiologica

Volume

51

Issue

8

Document type

Journal article

Publisher

SAGE Publications

Topic

  • Radiology, Nuclear Medicine and Medical Imaging

Keywords

  • nephropathy
  • contrast medium-induced
  • Contrast enhancement
  • coronary angiography

Status

Published

Research group

  • Radiology Diagnostics, Malmö

ISBN/ISSN/Other

  • ISSN: 1600-0455